Soleno Therapeutics, Inc. (SLNO) Dividend History

Company News

• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

  Pomerantz LLP is investigating potential securities fraud at Soleno Therapeutics after a Scorpion Capital report criticized their product Vykat XR, causing the stock to drop 7.41%.

  GlobeNewswire Inc.
• Soleno (SLNO) Q2 Revenue Jumps 30%

  Soleno Therapeutics reported its first commercial quarter with VYKAT XR for Prader-Willi syndrome, delivering $32.7 million in revenue, exceeding analyst expectations. The company showed promising early demand with 646 patient start forms and is preparing for potential European market entry.

  The Motley Fool
• Soleno Therapeutics enters agreement to sell $150 million in stock By Investing.com - Investing.com Canada

  Soleno Therapeutics, a medical device company, has entered into an agreement with Jefferies LLC to potentially sell up to $150 million of its common stock. The new funding option aims to bolster the company's financial flexibility and support its ongoing operations and strategic initiatives.

  Investing.com

  Featured Companies: JEF
• US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?

  U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc. (NASDAQ:AMZN) on Tuesday and Apple Inc. (NASDAQ:AAPL) on Thursday, a pivotal Federal Reserve Open Market Committee meeting on Wednesday, and the April’s jobs report on Friday. The S&P 500 rose 0.2% by midday trading in New York, following a 1% surge last Friday. Both the tech-heavy Nasdaq 100 and blue-chip stocks in the Dow Jones made similar gains. Small caps, as tracked by iShares Russell 2000 ETF (NYSE:IWM), outperformed large-cap stocks, rising as much as 0.9%. Tesla Inc. (NASDAQ:TSLA) grabbed the market spotlight by securing a significant partnership with Chinese search engine giant Baidu Inc. (NYSE:BIDU), which granted the Elon Musk-led company access to its mapping license for data collection on China’s public roads. The deal removes a last regulatory barrier for Tesla’s driver assistance system, known as Full Self-Driving (FSD), to be introduced in China. Shares of Tesla rose as much as 16% Monday. The Bank of Japan sent shockwaves through the ...Full story available on Benzinga.com

  Benzinga

  Featured Companies: AAPL ALB AMC AMZN BEN DIA DPZ EG FFIV IWM LSCC MSTR NXPI ON PARA PARAA QGEN QQQ RMBS RVTY SANM SOFI SPY TSLA XLC XLE XLK XLU XLY YUMC
• Soleno Therapeutics, Inc. (SLNO) Is a Great Choice for 'Trend' Investors, Here's Why

  If you are looking for stocks that are well positioned to maintain their recent uptrend, Soleno Therapeutics, Inc. (SLNO) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

  Zacks Investment Research